Inspire Veterinary Partners Inc
NASDAQ:IVP
NASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)

  • LAST PRICE
    0.2153
  • TODAY'S CHANGE (%)
    -0.0010 (-0.4623%)
  • Bid / Lots
    0.2100/ 90
  • Ask / Lots
    0.2180/ 50
  • Open / Previous Close
    0.2200 / 0.2163
  • Day Range
    0.2020
    0.2200
  • 52 Week Range
    0.1951
    70.2000
  • Volume
    918,530

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Nov 13, 2024

      Show headlines and story abstract

    • 6:22PM ET on Wednesday Nov 13, 2024 by MT Newswires
      Companies Mentioned: IVP
      06:22 PM EST, 11/13/2024 (MT Newswires) -- ...

    • 5:58PM ET on Wednesday Nov 13, 2024 by Dow Jones
      Companies Mentioned: IVP
      A preferred stock - - - - - - 2,567,866 - 2,567,866 Net loss - - - - - - - (7,884,002) (7,884,002) ------- ---- ------- ---- --------- ---- ---------- ------------ ------------ Balance as of September 30, 2023 442,458 $ 44 46,051 $ 5 3,891,500 $ 389 $19,606,132 $ (16,894,193) $ 2,712,376 ------- ---- ------- ---- --------- ---- ---------- ------------ ------------ Convertible Series A Class A Common Class B Common Preferred Stock Stock Stock --------------------------- ------------------- ------------------- Additional Stockholder' No. of No. of No. of Paid-in Accumulated Equity Shares Amount Shares Amount Shares Amount Capital Deficit (Deficit) ---------- ----------- ---------- ------- --------- -------- ----------- ------------ -------------- Balance as of December 31, 2023 403,640 $ 40 70,421 $ 7 3,891,500 $ 389 $20,426,562 $(21,215,257) $ (788,259) --------- ------- ---------- ------ --------- ---- ---------- ----------- ---------- Issuance of class A common stock and pre-funded warrants, net of issuance costs - - 28,599 3 - - 3,375,455 - 3,375,458 Exercise of pre-funded warrants - - 441,989 44 - - (44) - - Issuance of Class A common stock and pre-funded warrants in connection with commitment shares - - 12,143 1 - - 599,999 - 600,000 Issuance of convertible series A preferred stock 20,000 2 - - - - 199,998 - 200,000 Issuance of class A common stock for services - - 39,051 4 - - 286,692 - 286,696 Issuance of class A common stock in connection with general release agreement - - 2,460 - - - 20,000 - 20,000 Conversion of convertible series A preferred stock into class A common stock (363,725) (36) 147,900 15 - - 21 - - Convertible series A preferred stock cumulative dividends - - - - - - (2,250) - (2,250) Convertible series A preferred stock dividend 21,227 2 - - - - 212,268 (212,270) - Net loss - - - - - - - (3,421,792) (3,421,792) --------- ------- ---------- ------ --------- ---- ---------- ----------- ---------- Balance as of March 31, 2024 81,142 $ 8 742,563 $ 74 3,891,500 $ 389 $25,118,701 $(24,849,319) $ 269,853 --------- ------- ---------- ------ --------- ---- ---------- ----------- ---------- Exercise of pre-funded warrants - - 102,500 10 - - (10) - - Conversion of convertible series A preferred stock into class A common stock (54,771) (5) 198,992 20 - - (15) - - Convertible series A preferred stock dividend 858 - - - - - 10,830 (8,580) 2,250 Net loss - - - - - - - (3,386,421) (3,386,421) --------- ------- ---------- ------ --------- ---- ---------- ----------- ---------- Balance as of June 30, 2024 27,229 $ 3 1,044,055 $ 104 3,891,500 $ 389 $25,129,506 $(28,244,320) $ (3,114,318) --------- ------- ---------- ------ --------- ---- ---------- ----------- ---------- Issuance of class A common stock and warrants, net of issuance costs - - 146,475 15 - - 5,459,985 - 5,460,000 Exercise of pre-funded warrants - - 5,853,846 585 - - (585) - - Exercise of class A common stock warrants - - 3,500,000 350 - - 3,499,650 - 3,500,000 Conversion of convertible series A preferred stock into class A common stock (27,229) $ (3) 272,290 $ 27 - - (24) - - Conversion of convertible notes payable - - 2,547,022 255 - - 649,745 - 650,000 Stock-based compensation - - - - - - 23,647 - 23,647 Net loss - - - - - - - (3,489,326) (3,489,326) --------- ------- ---------- ------ --------- ---- ---------- ----------- ---------- Balance as of September 30, 2024 - $ - 13,363,688 $ 1,336 3,891,500 $ 389 $34,761,924 $(31,733,646) $ 3,030,003 --------- ------- ---------- ------ --------- ---- ---------- ----------- ----------

Peers Headlines